Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.
PLoS One. 2018 Jan 30;13(1):e0192335. doi: 10.1371/journal.pone.0192335. eCollection 2018.
PLoS One. 2018.
PMID: 29381749
Free PMC article.
T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.
Bughani U, Saha A, Kuriakose A, Nair R, Sadashivarao RB, Venkataraman R, Patel S, Deshchougule AT, S SK, Montero E, Pai HV, Palanivelu DV, Melarkode R, Nair P.
Bughani U, et al.
PLoS One. 2017 Jul 3;12(7):e0180088. doi: 10.1371/journal.pone.0180088. eCollection 2017.
PLoS One. 2017.
PMID: 28672038
Free PMC article.
Item in Clipboard
MK2: a novel molecular target for anti-inflammatory therapy.
Duraisamy S, Bajpai M, Bughani U, Dastidar SG, Ray A, Chopra P.
Duraisamy S, et al. Among authors: bughani u.
Expert Opin Ther Targets. 2008 Aug;12(8):921-36. doi: 10.1517/14728222.12.8.921.
Expert Opin Ther Targets. 2008.
PMID: 18620516
Review.
Item in Clipboard
Molecular targeting of E3 ligases--a therapeutic approach for cancer.
Lakshmanan M, Bughani U, Duraisamy S, Diwan M, Dastidar S, Ray A.
Lakshmanan M, et al. Among authors: bughani u.
Expert Opin Ther Targets. 2008 Jul;12(7):855-70. doi: 10.1517/14728222.12.7.855.
Expert Opin Ther Targets. 2008.
PMID: 18554154
Review.
Item in Clipboard
Enhanced soluble production of biologically active recombinant human p38 mitogen-activated-protein kinase (MAPK) in Escherichia coli.
Khattar SK, Gulati P, Kundu PK, Singh V, Bughani U, Bajpai M, Saini KS.
Khattar SK, et al. Among authors: bughani u.
Protein Pept Lett. 2007;14(8):756-60. doi: 10.2174/092986607781483660.
Protein Pept Lett. 2007.
PMID: 17979814
Item in Clipboard
BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth.
Boreddy SR, Nair R, Pandey PK, Kuriakose A, Marigowda SB, Dey C, Banerjee A, Kulkarni H, Sagar M, Krishn SR, Rao S, Ar M, Tiwari V, Alke B, Mv PK, Shri M, Dhamne C, Patel S, Sharma P, Periyasamy S, Bhatnagar J, Kuriakose MA, Reddy RB, Suresh A, Sreenivas S, Govindappa N, Moole PR, Bughani U, Tan SL, Nair P.
Boreddy SR, et al. Among authors: bughani u.
Cancer Res. 2023 Jun 2;83(11):1883-1904. doi: 10.1158/0008-5472.CAN-21-4425.
Cancer Res. 2023.
PMID: 37074042
Free PMC article.
Item in Clipboard
Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the Apc(Min/+) mouse model.
Li S, Ghaleb AM, He J, Bughani U, Bialkowska AB, Yang VW, Joshi HC.
Li S, et al. Among authors: bughani u.
Int J Cancer. 2012 Sep 15;131(6):1435-44. doi: 10.1002/ijc.27344. Epub 2012 Feb 9.
Int J Cancer. 2012.
PMID: 22052467
Free PMC article.
Item in Clipboard
Recent patents reveal microtubules as persistent promising target for novel drug development for cancers.
Bughani U, Li S, Joshi HC.
Bughani U, et al.
Recent Pat Antiinfect Drug Discov. 2009 Nov;4(3):164-82. doi: 10.2174/157489109789318532.
Recent Pat Antiinfect Drug Discov. 2009.
PMID: 19673697
Review.
Item in Clipboard
Cite
Cite